These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11595290)

  • 81. Can AIDS be prevented by T-cell vaccination?
    Atlan H; Gersten MJ; Salk PL; Salk J
    Immunol Today; 1993 May; 14(5):200-2. PubMed ID: 8517917
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Nonhuman Primate Models and Understanding the Pathogenesis of HIV Infection and AIDS.
    Veazey RS; Lackner AA
    ILAR J; 2017 Dec; 58(2):160-171. PubMed ID: 29228218
    [TBL] [Abstract][Full Text] [Related]  

  • 83. DNA vaccination by intradermal electroporation induces long-lasting immune responses in rhesus macaques.
    Kulkarni V; Rosati M; Jalah R; Ganneru B; Alicea C; Yu L; Guan Y; LaBranche C; Montefiori DC; King AD; Valentin A; Pavlakis GN; Felber BK
    J Med Primatol; 2014 Oct; 43(5):329-40. PubMed ID: 24810337
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Vaccination with Vaxfectin(®) adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia.
    Kulkarni V; Rosati M; Valentin A; Jalah R; Alicea C; Yu L; Guan Y; Shen X; Tomaras GD; LaBranche C; Montefiori DC; Irene C; Prattipati R; Pinter A; Sullivan SM; Pavlakis GN; Felber BK
    Hum Vaccin Immunother; 2013 Oct; 9(10):2069-80. PubMed ID: 23820294
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pulmonary vascular lesions are common in SIV- and SHIV-env-infected macaques.
    George MP; Brower A; Kling H; Shipley T; Kristoff J; Reinhart TA; Murphey-Corb M; Gladwin MT; Champion HC; Morris A; Norris KA
    AIDS Res Hum Retroviruses; 2011 Feb; 27(2):103-11. PubMed ID: 20961277
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Immunization with a Mixture of HIV Env DNA and VLP Vaccines Augments Induction of CD8 T Cell Responses.
    Ye L; Wen Z; Dong K; Pan L; Bu Z; Compans RW; Zhang H; Yang C
    J Biomed Biotechnol; 2010; 2010():497219. PubMed ID: 20508832
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization.
    Patel V; Valentin A; Kulkarni V; Rosati M; Bergamaschi C; Jalah R; Alicea C; Minang JT; Trivett MT; Ohlen C; Zhao J; Robert-Guroff M; Khan AS; Draghia-Akli R; Felber BK; Pavlakis GN
    Vaccine; 2010 Jul; 28(30):4827-36. PubMed ID: 20451642
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Update on animal models for HIV research.
    Haigwood NL
    Eur J Immunol; 2009 Aug; 39(8):1994-9. PubMed ID: 19672890
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine.
    Haut LH; Ertl HC
    J Leukoc Biol; 2009 Oct; 86(4):779-93. PubMed ID: 19597003
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.
    Tagmyer TL; Craigo JK; Cook SJ; Even DL; Issel CJ; Montelaro RC
    J Virol; 2008 Apr; 82(8):4052-63. PubMed ID: 18234792
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Selective induction of cell-mediated immunity and protection of rhesus macaques from chronic SHIV(KU2) infection by prophylactic vaccination with a conserved HIV-1 envelope peptide-cocktail.
    Nehete PN; Nehete BP; Hill L; Manuri PR; Baladandayuthapani V; Feng L; Simmons J; Sastry KJ
    Virology; 2008 Jan; 370(1):130-41. PubMed ID: 17920095
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Experimental Rhodococcus equi and equine infectious anemia virus DNA vaccination in adult and neonatal horses: effect of IL-12, dose, and route.
    Mealey RH; Stone DM; Hines MT; Alperin DC; Littke MH; Leib SR; Leach SE; Hines SA
    Vaccine; 2007 Oct; 25(43):7582-97. PubMed ID: 17889970
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Antigen expression kinetics and immune responses of mice immunized with noninfectious simian-human immunodeficiency virus DNA.
    Hegde R; Liu Z; Mackay G; Smith M; Chebloune Y; Narayan O; Singh DK
    J Virol; 2005 Dec; 79(23):14688-97. PubMed ID: 16282469
    [TBL] [Abstract][Full Text] [Related]  

  • 94. DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge.
    Rosati M; von Gegerfelt A; Roth P; Alicea C; Valentin A; Robert-Guroff M; Venzon D; Montefiori DC; Markham P; Felber BK; Pavlakis GN
    J Virol; 2005 Jul; 79(13):8480-92. PubMed ID: 15956591
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Enhanced cellular immunity in macaques following a novel peptide immunotherapy.
    Chea S; Dale CJ; De Rose R; Ramshaw IA; Kent SJ
    J Virol; 2005 Mar; 79(6):3748-57. PubMed ID: 15731268
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
    Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O
    J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques.
    Johnson PR; Schnepp BC; Connell MJ; Rohne D; Robinson S; Krivulka GR; Lord CI; Zinn R; Montefiori DC; Letvin NL; Clark KR
    J Virol; 2005 Jan; 79(2):955-65. PubMed ID: 15613324
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV89.6P envelope in a rhesus macaque.
    McKenna PM; Aye PP; Dietzschold B; Montefiori DC; Martin LN; Marx PA; Pomerantz RJ; Lackner A; Schnell MJ
    J Virol; 2004 Dec; 78(24):13455-9. PubMed ID: 15564456
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates.
    McDermott AB; Mitchen J; Piaskowski S; De Souza I; Yant LJ; Stephany J; Furlott J; Watkins DI
    J Virol; 2004 Mar; 78(6):3140-4. PubMed ID: 14990733
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome.
    McGettigan JP; Naper K; Orenstein J; Koser M; McKenna PM; Schnell MJ
    J Virol; 2003 Oct; 77(20):10889-99. PubMed ID: 14512539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.